S.BIOMEDICS completes brain transplant of hESC-derived dopaminergic progenitors (TED-A9) for Phase 1/2a study in patients with Parkinson’s disease
TED-A9 is high-purity midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under…